Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.49M Sell
9,650
-66
-0.7% -$22.6K 0.69% 52
2026
Q1
$3.42M Sell
9,716
-3
-0% -$1.07K 0.79% 50
2025
Q4
$3.18M Sell
9,719
-529
-5% -$168K 0.77% 54
2025
Q3
$2.89M Buy
10,248
+107
+1% +$31K 0.69% 61
2025
Q2
$2.83M Buy
10,141
+86
+0.9% +$24.4K 0.76% 59
2025
Q1
$3.13M Buy
10,055
+138
+1% +$40.8K 0.89% 53
2024
Q4
$2.58M Buy
+9,917
New +$2.94M 0.74% 61
2024
Q2
$2.16M Buy
6,907
+687
+11% +$202K 1.06% 44
2024
Q1
$1.77M Buy
6,220
+1,209
+24% +$354K 0.98% 51
2023
Q4
$1.44M Buy
+5,011
New +$1.37M 1.04% 47

Other funds holding AMGN

JPL Wealth Management's AMGN Position: Q2 2026 in Review

JPL Wealth Management reduced its Amgen (AMGN) stake by 0.68% in Q2 2026, selling an estimated $22.6K and leaving 9,650 shares worth $3.49M. The position accounts for 0.69% of the portfolio, ranked #52.

JPL Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • JPL Wealth Management held 9,650 shares of Amgen worth $3.49M as of Q2 2026.
  • JPL Wealth Management sold 66 Amgen shares in Q2 2026, an estimated $22.6K.
  • Amgen made up 0.69% of JPL Wealth Management's portfolio in Q2 2026, its #52 holding.
  • JPL Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.